ObvioGo, a leading provider of decentralized and patient-centric clinical trial technology, has completed integration with Oracle Life Sciences Clinical One Data Collection. The connection allows seamless, bidirectional data exchange between ObvioGo’s mobile platform and Oracle’s unified clinical trial suite, significantly simplifying remote data capture in modern trials.

Key features of the integration include: Real-time syncing of eCOA (electronic Clinical Outcome Assessments), ePRO (electronic Patient-Reported Outcomes), symptom diaries, medication adherence logs, and wearable data into Clinical One Automated data mapping and validation rules to ensure consistency and regulatory compliance Support for hybrid and fully decentralized trials patients enter data from home while sites monitor quality and compliance in real time Secure, audit-ready data flow aligned with FDA, EMA, and ICH guidelines

ObvioGo’s intuitive mobile app reduces patient burden by offering reminders, offline functionality, and multilingual support, while Oracle Clinical One provides sponsors with a single source of truth for all trial data EDC, eCOA, RTSM, and imaging. Together, the platforms help eliminate duplicate entry, minimize site workload, improve data timeliness, and enhance overall trial efficiency.

The partnership reflects the growing demand for interoperable, patient-friendly solutions in decentralized clinical research. By combining ObvioGo’s focus on participant experience with Oracle’s robust enterprise-grade infrastructure, the collaboration aims to support more inclusive, faster, and cost-effective studies across therapeutic areas.

The integration is now available for joint customers and is expected to be rolled out in ongoing and upcoming trials.